The regulatory environment for drug and device combination products is a dynamic one. Guidelines are everchanging and new discoveries are being made daily, sparking an industry evolution.
Rewatch this timely webinar with Alira Health’s Regulatory leadership team featuring key insights and advice for U.S. and EU companies as they map out their own regulatory pathways amid a rapidly evolving landscape.
Featuring cross-border regulatory experts, Mary McNamara-Cullinane, Senior Vice President Regulatory Affairs, Olga Carroll, Ph.D., Vice President Global Regulatory Affairs, Marie-Aude Ohresser, Vice President, Regulatory Affairs, EU, Ainoa Forteza, Manager, and hosted by Aude Ouensanga, Partner.
Watch the session replay below: